FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis (vol 28, pg 285, 2015)

被引：44
|
作者：
Dahan, Rony
Sega, Emanuela
Engelhardt, John
Selby, Mark
Korman, Alan J.
Ravetch, Jeffrey V.
机构：
来源：
CANCER CELL | 2015年 / 28卷 / 04期
关键词：
D O I：
10.1016/j.ccell.2015.09.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [21] PD-1/PD-L1 axis in organ fibrosis
    Zhao, Youliang
    Qu, Yaqian
    Hao, Changfu
    Yao, Wu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] The PD-1:PD-L1 axis in Inflammatory Arthritis
    Canavan, Mary
    Floudas, Achilleas
    Veale, Douglas J.
    Fearon, Ursula
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [23] PD-1/PD-L1 axis importance and tumor microenvironment immune cells
    Lotfinejad, Parisa
    Kazemi, Tohid
    Mokhtarzadeh, Ahad
    Shanehbandi, Dariush
    Niaragh, Farhad Jadidi
    Safaei, Sahar
    Asadi, Milad
    Baradaran, Behzad
    LIFE SCIENCES, 2020, 259
  • [24] The PD-1/PD-L1 Axis in the Biology of MASLD
    Pipitone, Rosaria Maria
    Lupo, Giulia
    Zito, Rossella
    Javed, Ayesha
    Petta, Salvatore
    Pennisi, Grazia
    Grimaudo, Stefania
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [25] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015)
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar R.
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (01) : 183 - 183
  • [26] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    Leukemia, 2015, 29 : 2110 - 2113
  • [27] Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
    Long, Yiru
    Yu, Xiaolu
    Chen, Runqiu
    Tong, Yongliang
    Gong, Likun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [29] Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy
    Khatoon, Elina
    Parama, Dey
    Kumar, Aviral
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Girisa, Sosmitha
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    LIFE SCIENCES, 2022, 306
  • [30] Hematologic Cancers Break Down a 'Checkpoint': Targeting the PD-1/PD-L1 Axis
    Timmerman, John
    ONCOLOGY-NEW YORK, 2015, 29 (06): : 440 - 441
12345